US Patent 11135263 Novel-anti-infective strategy against influenza virus and
Patent 11135263 was granted and assigned to Atriva Therapeutics on October, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 16, 2019
Date of Patent
October 5, 2021
Patent Applicant
Patent Application Number
20190916
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11135263 Novel-anti-infective strategy against influenza virus and
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
